HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, H. Articles by Espinoza-Delgado, I. Search for Related Content PubMed PubMed Citation Articles by Li, H. Articles by Espinoza-Delgado, I.

IFN- and T-bet Expression in Human Dendritic Cells from Normal Donors and Cancer Patients Is Controlled through Mechanisms Involving ERK-1/2-Dependent and IL-12-Independent Pathways

Section of Hematology-Oncology, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224

Dendritic cells (DC) play a major role in priming naive T cells and modulating the immune response. We have previously reported that bryostatin-1, a potent immune modulator with antitumor activity, activates monocytes and lymphocytes to produce cytokines. Studies have shown that tumor-bearing hosts have a Th1/Th2 cytokine pattern that is associated with decreased production of IFN-. We investigated the expression of IFN- in bryostatin-1-treated human DC. Bryostatin-1 induced both IFN- and T-bet mRNA expression in a dose- and time-dependent manner. As little as 1 ng/ml bryostatin-1 induced IFN- and T-bet transcripts within 3 h and protein at 12 h. Treatment of DC with cycloheximide revealed that bryostatin-1-induced T-bet expression requires de novo protein synthesis, but bryostatin-1-induced IFN- expression is independent of protein synthesis. Furthermore, dexamethasone inhibits bryostatin-1-induced IFN- mRNA expression but increases bryostatin-1-induced T-bet mRNA expression. Experiments with ERK-1/2 inhibitors demonstrated that bryostatin-1 induction of IFN- and T-bet was ERK-dependent and IL-12-independent. Similar results were obtained from both normal donors and cancer patients. In summary, our results suggest that bryostatin-1-induced IFN- expression is T-bet independent. They also suggest for the first time that IFN- and T-bet can be induced in human DC through an ERK-dependent pathway. Bryostatin-1-induced IFN- may play a crucial role in the initiation of the immune response, before specific recognition by T cells that could be beneficial in the treatment of cancer.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ Address correspondence and reprint requests to Dr. Igor Espinoza-Delgado, 5600 Nathan Shock Drive, Room 4C10, Baltimore, MD 21224. E-mail address: espinozaig{at}grc.nia.nih.gov

² Abbreviations used in this paper: PKC, protein kinase C; DC, dendritic cell; LGL, large granular lymphocyte; CHX, cycloheximide; DEX, dexamethasone; BI, bisindolylmaleimide I; BDCA, blood DC Ag; iDC, immature DC; mDC, mature DC; RT-qPCR, real-time quantitative PCR.

This article has been cited by other articles:

				M. W. Lipscomb, L. Chen, J. L. Taylor, C. Goldbach, S. C. Watkins, P. Kalinski, L. H. Butterfield, A. K. Wesa, and W. J. Storkus Ectopic T-bet Expression Licenses Dendritic Cells for IL-12-Independent Priming of Type 1 T Cells In Vitro J. Immunol., December 1, 2009; 183(11): 7250 - 7258. [Abstract] [Full Text] [PDF]